[1] CHEN W,SUN K,ZHENG R,et al.Cancer incidence and mortality in China, 2014[J]. Chin J Cancer Res, 2018,30(1):1-12.
[2] PETER S,JAMA S,ALVEN S,et al. Artemisinin and derivatives-based hybrid compounds: promising therapeutics for the treatment of cancer and malaria[J]. Molecules,2021,26(24):7521.
[6] BAI B, WU F, YING K, XU Y, et al. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer[J]. Theranostics,2021,11(13):6225-6239.
[11] DONG F, ZHOU X, LI C, et al. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis[J]. Cancer Biol Ther, 2014,15(11):1479-1488．
[13] SNEH V, PRASENJIT D, VIJAY LK. Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis[J]. Chem Biol Interact,2017,278:84-91.
[14] BUTTON R W, LIN F, ERCOLANO E, et al. Artesunate induces necrotic cell death in schwannoma cells[J].Cell Death Dis,2014,5(10):e1466.
[19] ZHU J,KONG W,XIE Z.Expression and Prognostic Characteristics of Ferroptosis-Related Genes in Colon Cancer[J].Int J Mol Sci,2021,22(11):5652.
[20] OOKO E, SAEED M E M, KADIOGLU O, et al. Artemisinin derivatives induce iron -dependent cell death （ferroptosis） in tumor cells[J].Phytomedicine,2015,22(11):1045-1054.
[21] YANG ND, TAN SH, NG S, et al. Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin[J].J Biol Chem,2014,289(48):33425-33441.
[22] OTTO-ŚLUSARCZYK D, MIELCZAREK-PUTA M,GRABOŃ W. The real cytotoxic effect of artemisinins on colon cancer cells in a physiological cell culture setting. How composition of the culture medium biases experimental findings [J]. Pharmaceuticals (Basel),2021,14(10):976.
[23] CHEN GQ, BENTHANI F A, WU J, et al. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis[J]. Cell Death Differ,2020,27(1):242-254.
